Meyer Vitabiotics, a leading pharmaceutical manufacturer, has conducted a study demonstrating the potential of antioxidant micronutrients and vitamins in improving male fertility. The research involved 300 Indian males with varying types and degrees of infertility, and tested the effectiveness of Oligocare Forte Plus, a supplement containing multi-vitamins, minerals, essential amino acids, ginseng, and lycopene. Results showed a 75.76% increase in sperm count among males with a baseline sperm count of less than 5 million/ml.
Male infertility is a significant global concern, with abnormalities in semen parameters often linked to male factor infertility. Existing treatment options, such as surgery, hormonal therapy, and drug therapy, are often associated with higher costs, uncertain clinical effectiveness, and side effects. Antioxidants have gained increasing interest among clinicians and researchers for boosting parameters of male fertility.
The Oligocare Forte Plus tablet, also known as Wellman Conception in the UK, combines essential micronutrients, amino acids, antioxidants, and vitamins crucial for male reproductive health. Antioxidants frequently prescribed for treating male infertility include vitamins E and C, carnitine, N-acetyl cysteine, selenium, and zinc. The study aimed to evaluate the safety, efficacy, and tolerability of the supplement, with results demonstrating promising outcomes for male infertility treatment.
Meyer Vitabiotics’ groundbreaking research offers hope for millions of men worldwide who suffer from male factor infertility, providing valuable insights into the impact of antioxidant therapy on improving semen parameters and the DNA Fragmentation Index (DFI). The results highlight the potential of antioxidant micronutrient therapy as a more accessible, cost-effective, and clinically efficient alternative to traditional treatment options for male infertility, offering a new perspective on male infertility treatment.